drugset / Trial / NCT00337272
Treating Chronic Insomnia in Breast Cancer Patients
Phase 4
Terminated
16 enrolled
Accelerated Community Oncology Research Network
Takeda Pharmaceuticals North America, Inc. · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is being conducted to evaluate the effectiveness of ramelteon 8mgs in the treatment of insomnia in patients that have completed their first chemotherapy treatment for breast cancer.
Timeline
- Start
- 2006-08
- Primary completion
- 2008-08
- Completion
- 2009-01
Outcome
Outcome not reported
Stopped (Enrollment): “Lack of enrollment.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ramelteon | Unknown | 8 mg | — |